SEC Form 4 · accession 0000886163-15-000026
LIGAND PHARMACEUTICALS INC · LGND
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Melanie J Herman
Officer — Director of Accounting
Period of report
Feb 19, 2015
Accepted (ET)
Feb 20, 2015 · 4:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000886163
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 19, 2015 | S | 510 | $57.84 | D | 3,521 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares sold to cover taxes on the vesting of restricted stock.